Le Lézard
Classified in: Health, Business
Subjects: CON, NPT, EXE

MRIGlobal Continues Support for Shelf Life Evaluations of Investigational Dosage Forms


KANSAS CITY, Mo., March 27, 2018 /PRNewswire-USNewswire/ -- MRIGlobal today announced the award of a five-year contract by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) for Shelf Life Evaluation of Investigational Dosage Forms. 

MRIGlobal Logo. (PRNewsFoto/MRIGlobal)

Valued at $2,999,743, the contract was awarded in support of NCI's Division of Cancer Treatment and Diagnosis.

MRIGlobal has supported this program since 2002, which involves shelf-life stability analytical testing for cancer chemotherapeutic compounds that are under clinical development at the NCI. Information regarding the proper storage and handling of various drug products and determination of appropriate expiration dates for the products supports NCI's Investigational New Drug Applications filed with the Food and Drug Administration.

"We are all working toward a world without cancer," said Thomas M. Sack, Ph.D., MRIGlobal President and Chief Executive Officer. "Our scientists take pride in working with NCI to combat this devastating disease."  

This project is funded by the National Cancer Institute at the National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN261201800003C.

About MRIGlobal
MRIGlobal addresses some of the world's greatest threats and challenges. Founded in 1944 as an independent, non-profit organization, we perform contract research for government, industry, and academia. Our customized solutions in national security and defense and health include research and development capabilities in clinical research support, infectious disease and biological threat agent detection, global biological engagement, in vitro diagnostics, and laboratory management and operations. MRIGlobal is one of two partners in the Alliance for Sustainable Energy, LLC, which manages and operates the National Renewable Energy Laboratory (NREL) in Golden, Colo., for the U.S. Department of Energy. For more information, visit mriglobal.org.

SOURCE MRIGlobal


These press releases may also interest you

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...



News published on and distributed by: